Brim Biotechnology Inc.
Clinical trials sponsored by Brim Biotechnology Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New eye drop aims to beat artificial tears for dry eye relief Results expected Nov 2026 (estimated)
-
New eye drops aim to soothe dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely reduce the signs and symptoms of dry eye compared to a placebo. 220 adults with dry eye for at least 6 months received either the active drops or a placebo. The main outcomes were changes in corneal staining (eye surface damag…
Phase 2/3 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
New eye drop shows promise for dry eye sufferers
Symptom relief CompletedThis study tested whether BRM421 eye drops can safely ease the signs and symptoms of dry eye. 157 adults with dry eye for at least 6 months received either the active drops or a placebo. The trial measured changes in corneal staining and discomfort scores. Results suggest the dro…
Phase 2 • Sponsor: BRIM Biotechnology Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC